The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Total Intravenous Anesthesia (TIVA) Market Research Report 2025
Synopsis
Total intravenous anaesthesia (TIVA) is a technique of general anaesthesia, which uses a combination of agents given exclusively by the intravenous route without the use of inhalation agents (Gas Anaesthesia).
The global Total Intravenous Anesthesia (TIVA) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Total Intravenous Anesthesia (TIVA) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Total Intravenous Anesthesia (TIVA) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Total Intravenous Anesthesia (TIVA) include B. Braun Medical, Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, Maruishi, Piramal, Hikma Pharmaceuticals and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Total Intravenous Anesthesia (TIVA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Intravenous Anesthesia (TIVA).
Report Scope
The Total Intravenous Anesthesia (TIVA) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Total Intravenous Anesthesia (TIVA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Total Intravenous Anesthesia (TIVA) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun Medical
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan
Segment by Type
Propofol
Etomidate
Midazolam
Barbiturates
Others
Segment by Application
Predominantly Emergency
Orthopedic
Cosmetic Surgeries
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Total Intravenous Anesthesia (TIVA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Total Intravenous Anesthesia (TIVA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Total intravenous anaesthesia (TIVA) is a technique of general anaesthesia, which uses a combination of agents given exclusively by the intravenous route without the use of inhalation agents (Gas Anaesthesia).
The global Total Intravenous Anesthesia (TIVA) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Total Intravenous Anesthesia (TIVA) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Total Intravenous Anesthesia (TIVA) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Total Intravenous Anesthesia (TIVA) include B. Braun Medical, Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, Maruishi, Piramal, Hikma Pharmaceuticals and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Total Intravenous Anesthesia (TIVA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Intravenous Anesthesia (TIVA).
Report Scope
The Total Intravenous Anesthesia (TIVA) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Total Intravenous Anesthesia (TIVA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Total Intravenous Anesthesia (TIVA) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun Medical
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan
Segment by Type
Propofol
Etomidate
Midazolam
Barbiturates
Others
Segment by Application
Predominantly Emergency
Orthopedic
Cosmetic Surgeries
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Total Intravenous Anesthesia (TIVA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Total Intravenous Anesthesia (TIVA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Total Intravenous Anesthesia (TIVA) Market Overview
1.1 Product Overview and Scope of Total Intravenous Anesthesia (TIVA)
1.2 Total Intravenous Anesthesia (TIVA) Segment by Type
1.2.1 Global Total Intravenous Anesthesia (TIVA) Market Value Comparison by Type (2024-2030)
1.2.2 Propofol
1.2.3 Etomidate
1.2.4 Midazolam
1.2.5 Barbiturates
1.2.6 Others
1.3 Total Intravenous Anesthesia (TIVA) Segment by Application
1.3.1 Global Total Intravenous Anesthesia (TIVA) Market Value by Application: (2024-2030)
1.3.2 Predominantly Emergency
1.3.3 Orthopedic
1.3.4 Cosmetic Surgeries
1.3.5 Others
1.4 Global Total Intravenous Anesthesia (TIVA) Market Size Estimates and Forecasts
1.4.1 Global Total Intravenous Anesthesia (TIVA) Revenue 2019-2030
1.4.2 Global Total Intravenous Anesthesia (TIVA) Sales 2019-2030
1.4.3 Global Total Intravenous Anesthesia (TIVA) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Total Intravenous Anesthesia (TIVA) Market Competition by Manufacturers
2.1 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Total Intravenous Anesthesia (TIVA) Average Price by Manufacturers (2019-2024)
2.4 Global Total Intravenous Anesthesia (TIVA) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Total Intravenous Anesthesia (TIVA), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Total Intravenous Anesthesia (TIVA), Product Type & Application
2.7 Total Intravenous Anesthesia (TIVA) Market Competitive Situation and Trends
2.7.1 Total Intravenous Anesthesia (TIVA) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Total Intravenous Anesthesia (TIVA) Players Market Share by Revenue
2.7.3 Global Total Intravenous Anesthesia (TIVA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Total Intravenous Anesthesia (TIVA) Retrospective Market Scenario by Region
3.1 Global Total Intravenous Anesthesia (TIVA) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Total Intravenous Anesthesia (TIVA) Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2019-2030
3.2.1 Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2019-2024
3.2.2 Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2025-2030
3.3 Global Total Intravenous Anesthesia (TIVA) Global Total Intravenous Anesthesia (TIVA) Revenue by Region: 2019-2030
3.3.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Region: 2019-2024
3.3.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Region: 2025-2030
3.4 North America Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
3.4.1 North America Total Intravenous Anesthesia (TIVA) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Total Intravenous Anesthesia (TIVA) Sales by Country (2019-2030)
3.4.3 North America Total Intravenous Anesthesia (TIVA) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
3.5.1 Europe Total Intravenous Anesthesia (TIVA) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2019-2030)
3.5.3 Europe Total Intravenous Anesthesia (TIVA) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
3.6.1 Asia Pacific Total Intravenous Anesthesia (TIVA) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Country (2019-2030)
3.6.3 Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
3.7.1 Latin America Total Intravenous Anesthesia (TIVA) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Total Intravenous Anesthesia (TIVA) Sales by Country (2019-2030)
3.7.3 Latin America Total Intravenous Anesthesia (TIVA) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country
3.8.1 Middle East and Africa Total Intravenous Anesthesia (TIVA) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Total Intravenous Anesthesia (TIVA) Sales by Type (2019-2030)
4.1.1 Global Total Intravenous Anesthesia (TIVA) Sales by Type (2019-2024)
4.1.2 Global Total Intravenous Anesthesia (TIVA) Sales by Type (2025-2030)
4.1.3 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2019-2030)
4.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2019-2030)
4.2.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2019-2024)
4.2.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2025-2030)
4.2.3 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2019-2030)
4.3 Global Total Intravenous Anesthesia (TIVA) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Total Intravenous Anesthesia (TIVA) Sales by Application (2019-2030)
5.1.1 Global Total Intravenous Anesthesia (TIVA) Sales by Application (2019-2024)
5.1.2 Global Total Intravenous Anesthesia (TIVA) Sales by Application (2025-2030)
5.1.3 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2019-2030)
5.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2019-2030)
5.2.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2019-2024)
5.2.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2025-2030)
5.2.3 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2019-2030)
5.3 Global Total Intravenous Anesthesia (TIVA) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 B. Braun Medical
6.1.1 B. Braun Medical Corporation Information
6.1.2 B. Braun Medical Description and Business Overview
6.1.3 B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Portfolio
6.1.5 B. Braun Medical Recent Developments/Updates
6.2 Astrazeneca
6.2.1 Astrazeneca Corporation Information
6.2.2 Astrazeneca Description and Business Overview
6.2.3 Astrazeneca Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Astrazeneca Total Intravenous Anesthesia (TIVA) Product Portfolio
6.2.5 Astrazeneca Recent Developments/Updates
6.3 Fresenius-Kabi
6.3.1 Fresenius-Kabi Corporation Information
6.3.2 Fresenius-Kabi Description and Business Overview
6.3.3 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Portfolio
6.3.5 Fresenius-Kabi Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Corporation Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AbbVie Total Intravenous Anesthesia (TIVA) Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Baxter Healthcare
6.5.1 Baxter Healthcare Corporation Information
6.5.2 Baxter Healthcare Description and Business Overview
6.5.3 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Portfolio
6.5.5 Baxter Healthcare Recent Developments/Updates
6.6 Maruishi
6.6.1 Maruishi Corporation Information
6.6.2 Maruishi Description and Business Overview
6.6.3 Maruishi Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Maruishi Total Intravenous Anesthesia (TIVA) Product Portfolio
6.6.5 Maruishi Recent Developments/Updates
6.7 Piramal
6.6.1 Piramal Corporation Information
6.6.2 Piramal Description and Business Overview
6.6.3 Piramal Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Piramal Total Intravenous Anesthesia (TIVA) Product Portfolio
6.7.5 Piramal Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Corporation Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Total Intravenous Anesthesia (TIVA) Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Nhwa
6.10.1 Nhwa Corporation Information
6.10.2 Nhwa Description and Business Overview
6.10.3 Nhwa Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nhwa Total Intravenous Anesthesia (TIVA) Product Portfolio
6.10.5 Nhwa Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Corporation Information
6.11.2 Hengrui Total Intravenous Anesthesia (TIVA) Description and Business Overview
6.11.3 Hengrui Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hengrui Total Intravenous Anesthesia (TIVA) Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Lunan
6.12.1 Lunan Corporation Information
6.12.2 Lunan Total Intravenous Anesthesia (TIVA) Description and Business Overview
6.12.3 Lunan Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Lunan Total Intravenous Anesthesia (TIVA) Product Portfolio
6.12.5 Lunan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Total Intravenous Anesthesia (TIVA) Industry Chain Analysis
7.2 Total Intravenous Anesthesia (TIVA) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Total Intravenous Anesthesia (TIVA) Production Mode & Process
7.4 Total Intravenous Anesthesia (TIVA) Sales and Marketing
7.4.1 Total Intravenous Anesthesia (TIVA) Sales Channels
7.4.2 Total Intravenous Anesthesia (TIVA) Distributors
7.5 Total Intravenous Anesthesia (TIVA) Customers
8 Total Intravenous Anesthesia (TIVA) Market Dynamics
8.1 Total Intravenous Anesthesia (TIVA) Industry Trends
8.2 Total Intravenous Anesthesia (TIVA) Market Drivers
8.3 Total Intravenous Anesthesia (TIVA) Market Challenges
8.4 Total Intravenous Anesthesia (TIVA) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Total Intravenous Anesthesia (TIVA) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Total Intravenous Anesthesia (TIVA) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Total Intravenous Anesthesia (TIVA) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Total Intravenous Anesthesia (TIVA) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Total Intravenous Anesthesia (TIVA) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Total Intravenous Anesthesia (TIVA), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Total Intravenous Anesthesia (TIVA), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Total Intravenous Anesthesia (TIVA), Product Type & Application
Table 12. Global Key Manufacturers of Total Intravenous Anesthesia (TIVA), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Total Intravenous Anesthesia (TIVA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Total Intravenous Anesthesia (TIVA) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Total Intravenous Anesthesia (TIVA) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Total Intravenous Anesthesia (TIVA) Sales by Region (2019-2024) & (K Units)
Table 18. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2019-2024)
Table 19. Global Total Intravenous Anesthesia (TIVA) Sales by Region (2025-2030) & (K Units)
Table 20. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2025-2030)
Table 21. Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2019-2024)
Table 23. Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2025-2030)
Table 25. North America Total Intravenous Anesthesia (TIVA) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Total Intravenous Anesthesia (TIVA) Sales by Country (2019-2024) & (K Units)
Table 27. North America Total Intravenous Anesthesia (TIVA) Sales by Country (2025-2030) & (K Units)
Table 28. North America Total Intravenous Anesthesia (TIVA) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Total Intravenous Anesthesia (TIVA) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Total Intravenous Anesthesia (TIVA) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Total Intravenous Anesthesia (TIVA) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Total Intravenous Anesthesia (TIVA) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Total Intravenous Anesthesia (TIVA) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Total Intravenous Anesthesia (TIVA) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Total Intravenous Anesthesia (TIVA) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Total Intravenous Anesthesia (TIVA) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Total Intravenous Anesthesia (TIVA) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) by Type (2019-2024)
Table 51. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) by Type (2025-2030)
Table 52. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2019-2024)
Table 53. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2025-2030)
Table 54. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2019-2024)
Table 57. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2025-2030)
Table 58. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Type (2019-2024)
Table 59. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Type (2025-2030)
Table 60. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) by Application (2019-2024)
Table 61. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) by Application (2025-2030)
Table 62. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2019-2024)
Table 63. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2025-2030)
Table 64. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2019-2024)
Table 67. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2025-2030)
Table 68. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Application (2019-2024)
Table 69. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Application (2025-2030)
Table 70. B. Braun Medical Corporation Information
Table 71. B. Braun Medical Description and Business Overview
Table 72. B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. B. Braun Medical Total Intravenous Anesthesia (TIVA) Product
Table 74. B. Braun Medical Recent Developments/Updates
Table 75. Astrazeneca Corporation Information
Table 76. Astrazeneca Description and Business Overview
Table 77. Astrazeneca Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Astrazeneca Total Intravenous Anesthesia (TIVA) Product
Table 79. Astrazeneca Recent Developments/Updates
Table 80. Fresenius-Kabi Corporation Information
Table 81. Fresenius-Kabi Description and Business Overview
Table 82. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product
Table 84. Fresenius-Kabi Recent Developments/Updates
Table 85. AbbVie Corporation Information
Table 86. AbbVie Description and Business Overview
Table 87. AbbVie Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AbbVie Total Intravenous Anesthesia (TIVA) Product
Table 89. AbbVie Recent Developments/Updates
Table 90. Baxter Healthcare Corporation Information
Table 91. Baxter Healthcare Description and Business Overview
Table 92. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product
Table 94. Baxter Healthcare Recent Developments/Updates
Table 95. Maruishi Corporation Information
Table 96. Maruishi Description and Business Overview
Table 97. Maruishi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Maruishi Total Intravenous Anesthesia (TIVA) Product
Table 99. Maruishi Recent Developments/Updates
Table 100. Piramal Corporation Information
Table 101. Piramal Description and Business Overview
Table 102. Piramal Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Piramal Total Intravenous Anesthesia (TIVA) Product
Table 104. Piramal Recent Developments/Updates
Table 105. Hikma Pharmaceuticals Corporation Information
Table 106. Hikma Pharmaceuticals Description and Business Overview
Table 107. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product
Table 109. Hikma Pharmaceuticals Recent Developments/Updates
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Mylan Total Intravenous Anesthesia (TIVA) Product
Table 114. Mylan Recent Developments/Updates
Table 115. Nhwa Corporation Information
Table 116. Nhwa Description and Business Overview
Table 117. Nhwa Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Nhwa Total Intravenous Anesthesia (TIVA) Product
Table 119. Nhwa Recent Developments/Updates
Table 120. Hengrui Corporation Information
Table 121. Hengrui Description and Business Overview
Table 122. Hengrui Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Hengrui Total Intravenous Anesthesia (TIVA) Product
Table 124. Hengrui Recent Developments/Updates
Table 125. Lunan Corporation Information
Table 126. Lunan Description and Business Overview
Table 127. Lunan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Lunan Total Intravenous Anesthesia (TIVA) Product
Table 129. Lunan Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Total Intravenous Anesthesia (TIVA) Distributors List
Table 133. Total Intravenous Anesthesia (TIVA) Customers List
Table 134. Total Intravenous Anesthesia (TIVA) Market Trends
Table 135. Total Intravenous Anesthesia (TIVA) Market Drivers
Table 136. Total Intravenous Anesthesia (TIVA) Market Challenges
Table 137. Total Intravenous Anesthesia (TIVA) Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Total Intravenous Anesthesia (TIVA)
Figure 2. Global Total Intravenous Anesthesia (TIVA) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Total Intravenous Anesthesia (TIVA) Market Share by Type in 2023 & 2030
Figure 4. Propofol Product Picture
Figure 5. Etomidate Product Picture
Figure 6. Midazolam Product Picture
Figure 7. Barbiturates Product Picture
Figure 8. Others Product Picture
Figure 9. Global Total Intravenous Anesthesia (TIVA) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Total Intravenous Anesthesia (TIVA) Market Share by Application in 2023 & 2030
Figure 11. Predominantly Emergency
Figure 12. Orthopedic
Figure 13. Cosmetic Surgeries
Figure 14. Others
Figure 15. Global Total Intravenous Anesthesia (TIVA) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Total Intravenous Anesthesia (TIVA) Market Size (2019-2030) & (US$ Million)
Figure 17. Global Total Intravenous Anesthesia (TIVA) Sales (2019-2030) & (K Units)
Figure 18. Global Total Intravenous Anesthesia (TIVA) Average Price (US$/Unit) & (2019-2030)
Figure 19. Total Intravenous Anesthesia (TIVA) Report Years Considered
Figure 20. Total Intravenous Anesthesia (TIVA) Sales Share by Manufacturers in 2023
Figure 21. Global Total Intravenous Anesthesia (TIVA) Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Total Intravenous Anesthesia (TIVA) Players: Market Share by Revenue in 2023
Figure 23. Total Intravenous Anesthesia (TIVA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Total Intravenous Anesthesia (TIVA) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2019-2030)
Figure 26. North America Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2019-2030)
Figure 27. United States Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2019-2030)
Figure 30. Europe Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2019-2030)
Figure 31. Germany Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2019-2030)
Figure 38. China Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2019-2030)
Figure 48. Latin America Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Total Intravenous Anesthesia (TIVA) by Type (2019-2030)
Figure 58. Global Revenue Market Share of Total Intravenous Anesthesia (TIVA) by Type (2019-2030)
Figure 59. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Total Intravenous Anesthesia (TIVA) by Application (2019-2030)
Figure 61. Global Revenue Market Share of Total Intravenous Anesthesia (TIVA) by Application (2019-2030)
Figure 62. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Application (2019-2030)
Figure 63. Total Intravenous Anesthesia (TIVA) Value Chain
Figure 64. Total Intravenous Anesthesia (TIVA) Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
